| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |